<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR16">
 <label>16.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Johnson</surname>
    <given-names>NA</given-names>
   </name>
   <name>
    <surname>Priefer</surname>
    <given-names>R</given-names>
   </name>
  </person-group>
  <article-title>Assessment of the approved risk evaluation and mitigation strategy programs for new drug applications and biologics licensing applications</article-title>
  <source>Regul Toxicol Pharmacol</source>
  <year>2019</year>
  <volume>101</volume>
  <fpage>53</fpage>
  <lpage>56</lpage>
  <pub-id pub-id-type="doi">10.1016/j.yrtph.2018.10.014</pub-id>
  <pub-id pub-id-type="pmid">30473489</pub-id>
 </element-citation>
</ref>
